Zomedica Corp [AMEX: ZOM] surged by $0.0 during the normal trading session on while it closed the day at $0.15.
Zomedica Corp stock has also loss -0.07% of its value over the past 7 days. However, ZOM stock has inclined by 15.21% in the 3 months of the year. Over the past six months meanwhile, it has gained 12.70% and lost -25.07% year-on date.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for ZOM stock reached $146.99 million, with 979.95 million shares outstanding and 962.81 million shares in the current float. Compared to the average trading volume of 5.07M shares, ZOM reached a trading volume of 3074505 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Zomedica Corp [ZOM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ZOM shares is $0.44 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ZOM stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Dawson James have made an estimate for Zomedica Corp shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 06, 2023.
The Average True Range (ATR) for Zomedica Corp is set at 0.01, with the Price to Sales ratio for ZOM stock in the period of the last 12 months amounting to 5.66. The Price to Book ratio for the last quarter was 0.63, with the Price to Cash per share for the same quarter was set at 0.08.
ZOM stock trade performance evaluation
Zomedica Corp [ZOM] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.07. With this latest performance, ZOM shares gained by 6.76% in over the last four-week period, additionally plugging by 12.70% over the last 6 months – not to mention a drop of -26.11% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ZOM stock in for the last two-week period is set at 49.98, with the RSI for the last a single of trading hit 50.30, and the three-weeks RSI is set at 49.82 for Zomedica Corp [ZOM]. The present Moving Average for the last 50 days of trading for this stock 0.1553, while it was recorded at 0.1505 for the last single week of trading, and 0.1545 for the last 200 days.
Zomedica Corp [ZOM]: An insightful look at the core fundamentals
Zomedica Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 10.87 and a Current Ratio set at 11.50.
Zomedica Corp [ZOM]: Institutional Ownership
The top three institutional holders of ZOM stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in ZOM stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in ZOM stock with ownership which is approximately 5.1238%.
